Trial intelligence / Profile preview

Morphine and Nortriptyline in Postherpetic Neuralgia

NCT00004390Phase 3Completed

Sponsor
National Center for Research Resources
Start
Feb 1995
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Morphine, Nortriptyline and Placebo (3 arms). Primary endpoint: Management of pain at 6 weeks. Started Feb 1995; status: completed.

02

Drugs

morphinenortriptyline
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT00004390.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004390.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call